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Background
Epigenetic mechanisms such as post-translational his-
tone acetylation are increasingly recognized for their
contribution to gene activation and silencing in the
brain and contribute to neurodegeneration. Acetylation
degree of histones is highly regulated by the enzymes
known as histone acetyltransferases (HATs) or histone
deacetylases (HDACs). HDAC inhibition affects the
expression of only a small subset of genes, leading to
transcriptional activation or repression through hypera-
cetylation of histone or non-histone proteins. HDAC
inhibitors are a class of compounds that interfere with
the function of HDAC and have been viewed as promis-
ing agents to combat neurodegenerative diseases such as
Alzheimer’s disease (AD) and Parkinson’s disease (PD).
Multiple mechanisms underlying the effects of HDAC
inhibitors on neuroprotection and restoration of memory
and motor impairments in AD or PD models have been
proposed, however, little is known about the contribution
of HDAC inhibition in glial cells. It has been reported
that valproic acid (VPA), a drug commonly used for epi-
lepsy and bipolar disorders, upregulates the expression of
neurotrophic factors, including glial cell line-derived neu-
rotrophic factor (GDNF) and brain-derived neurotrophic
factor (BDNF) in astrocytes, which contributes to VPA-
mediated neurotrophic effect on dopamine neurons. VPA
also induces microglia apoptosis and suppresses the pro-
duction of proinflammatory factors in microglia. As VPA
is a HDAC inhibitor, we hypothesize that HDAC inhibi-
tion may contribute to neuroprotection through regulat-
ing gene expressions in glial cells.
Materials and methods
We thus investigated the effects of several HDAC inhibi-
tors including VPA, trichostatin (TSA), sodium phenylbu-
tyrate (4-PBA) and nicotinamide, on neurotrophic and
proinflammatory functions of astrocytes and microglia.
Results
Our results indicate that (1) VPA and TSA increased
GDNF and BDNF transcripts in astrocytes that might be
attributable, at least in part, to histone hyperacetylation in
specific gene promoters as GDNF promoter activity and
promoter-associated histone H3 acetylation level were
elevated; (2) both 4-PBA and nicotinamide decreased the
cell viability and release of TNF alpha and nitric oxide
from cultured microglia stimulated with the inflammagen
lipopolysaccharide (LPS). (3) VPA, TSA and 4-PBA
protected dopamine neurons in neuron/glia co-cultures
challenged with MPTP or LPS; (4) PBA reduced TNF
alpha expression in the brain of C57 mice intraperitoneally
injected with LPS with no effect on microglia cell count.
Conclusions
In summary, histone acetylation is involved in regulation
of glial functions and may thus contributes to neurodeg-
neration or neuropretection. Further studies on HDAC
inhibition in glial cells in AD and PD animal models are
warranted to gain a more comprehensive understanding of
the mechanisms underlying actions of HDAC inhibitors in
the brain.
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